ArticleGenes2023

Interplay between microRNAs, Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9), and Lipid Parameters in Patients with Very High Lipoprotein(a) Treated with PCSK9 Inhibitors.

Tina Levstek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.